Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR–Cas9 for genome engineering. Cell 157, 1262–1278 (2014).
Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770–788 (2018).
Yang, B., Yang, L. & Chen, J. Development and application of base editors. CRISPR J. 2, 91–104 (2019).
Yang, L. & Chen, J. A tale of two moieties: rapidly evolving CRISPR/Cas-based genome editing. Trends Biochem. Sci. 45, 874–888 (2020).
Li, G. et al. Gene editing and its applications in biomedicine. Sci. China Life Sci. 65, 660–700 (2022).
Li, X. et al. Base editing with a Cpf1-cytidine deaminase fusion. Nat. Biotechnol. 36, 324–327 (2018).
Wang, J. Y. & Doudna, J. A. CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643 (2023).
Kim, J. S. & Chen, J. Base editing of organellar DNA with programmable deaminases. Nat. Rev. Mol. Cell Biol. 25, 34–45 (2024).
Khosravi, H. M. & Jantsch, M. F. Site-directed RNA editing: recent advances and open challenges. RNA Biol. 18, 41–50 (2021).
Pfeiffer, L. S. & Stafforst, T. Precision RNA base editing with engineered and endogenous effectors. Nat. Biotechnol. 41, 1526–1542 (2023).
Booth, B. J. et al. RNA editing: expanding the potential of RNA therapeutics. Mol. Ther. 31, 1533–1549 (2023).
Fu, Z. C., Gao, B. Q., Nan, F., Ma, X. K. & Yang, L. DEMINING: a deep learning model embedded framework to distinguish RNA editing from DNA mutations in RNA sequencing data. Genome Biol. 25, 258 (2024).
Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133–138 (2019).
Qu, L. et al. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat. Biotechnol. 37, 1059–1069 (2019).
Reautschnig, P. et al. CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat. Biotechnol. 40, 759–768 (2022).
Yi, Z. et al. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat. Biotechnol. 40, 946–955 (2022).
Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938–945 (2022).
Reautschnig, P. et al. Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02313-0 (2024).
Riedmann, E. M., Schopoff, S., Hartner, J. C. & Jantsch, M. F. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 14, 1110–1118 (2008).
Kuttan, A. & Bass, B. L. Mechanistic insights into editing-site specificity of ADARs. Proc. Natl Acad. Sci. USA 109, E3295–E3304 (2012).
Montiel-Gonzalez, M. F., Vallecillo-Viejo, I., Yudowski, G. A. & Rosenthal, J. J. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc. Natl Acad. Sci. USA 110, 18285–18290 (2013).
Vogel, P. et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat. Methods 15, 535–538 (2018).
Kiran Kumar, K. D. et al. An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification. Nat. Commun. 15, 6615 (2024).
Katrekar, D. et al. In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nat. Methods 16, 239–242 (2019).
Cox, D. B. T. et al. RNA editing with CRISPR–Cas13. Science 358, 1019–1027 (2017).
Kannan, S. et al. Compact RNA editors with small Cas13 proteins. Nat. Biotechnol. 40, 194–197 (2022).
Liu, Y. et al. REPAIRx, a specific yet highly efficient programmable A > I RNA base editor. EMBO J. 39, e104748 (2020).
Xiao, Q. et al. Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor. Sci. Transl. Med. 14, eabn0449 (2022).
Wang, L. et al. Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nat. Cell Biol. 23, 552–563 (2021).
Han, W. et al. Design and application of the transformer base editor in mammalian cells and mice. Nat. Protoc. 18, 3194–3228 (2023).
Han, W. et al. Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs. Cell Stem Cell 30, 1624–1639 (2023).
Katrekar, D. et al. Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity. eLife 11, e75555 (2022).
Wang, Y. et al. ecRESCUE: a novel ecDHFR-regulated RESCUE system with reduced RNA off-targeting activity. Cell Commun. Signal. 19, 81 (2021).
Wang, X. et al. Cas12a base editors induce efficient and specific editing with low DNA damage response. Cell Rep. 31, 107723 (2020).
Liu, Z., Chen, S., Lai, L. & Li, Z. Inhibition of base editors with anti-deaminases derived from viruses. Nat. Commun. 13, 597 (2022).
Oakes, E., Anderson, A., Cohen-Gadol, A. & Hundley, H. A. Adenosine deaminase that acts on RNA 3 (ADAR3) binding to glutamate receptor subunit B pre-mRNA inhibits RNA editing in glioblastoma. J. Biol. Chem. 292, 4326–4335 (2017).
Conticello, S. G., Harris, R. S. & Neuberger, M. S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13, 2009–2013 (2003).
Li, Y. L. et al. The structural basis for HIV-1 Vif antagonism of human APOBEC3G. Nature 615, 728–733 (2023).
Salter, J. D., Bennett, R. P. & Smith, H. C. The APOBEC protein family: united by structure, divergent in function. Trends Biochem. Sci. 41, 578–594 (2016).
Yang, B., Li, X., Lei, L. & Chen, J. APOBEC: from mutator to editor. J. Genet. Genomics 44, 423–437 (2017).
Pecori, R., Di Giorgio, S., Paulo Lorenzo, J. & Nina Papavasiliou, F. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nat. Rev. Genet. 23, 505–518 (2022).
Xiang, J. et al. Nucleoside deaminases: the key players in base editing toolkit. Biophys. Rep. 9, 325–337 (2023).
Gray, D. C., Mahrus, S. & Wells, J. A. Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell 142, 637–646 (2010).
Szymczak-Workman, A. L., Vignali, K. M. & Vignali, D. A. Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harb. Protoc. 2012, 199–204 (2012).
Matthews, M. M. et al. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat. Struct. Mol. Biol. 23, 426–433 (2016).
Roth, S. H., Levanon, E. Y. & Eisenberg, E. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity. Nat. Methods 16, 1131–1138 (2019).
Pinto, Y., Cohen, H. Y. & Levanon, E. Y. Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol. 15, R5 (2014).
Wang, D. et al. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol. Genet. Metab. 99, 62–71 (2010).
Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Yang, L., Yang, B. & Chen, J. One prime for all editing. Cell 179, 1448–1450 (2019).
Chen, P. J. et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184, 5635–5652 (2021).
Li, X. et al. Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure. Nat. Commun. 13, 1669 (2022).
Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358–378 (2019).
Lykke-Andersen, S. & Jensen, T. H. Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat. Rev. Mol. Cell Biol. 16, 665–677 (2015).
Yi, Z. et al. Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice. Genome Biol. 24, 243 (2023).
Monian, P. et al. Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides. Nat. Biotechnol. 40, 1093–1102 (2022).
Erion, D. M., Liu, L. Y., Brown, C. R., Rennard, S. & Farah, H. Editing approaches to treat α-1 antitrypsin deficiency. Chest 167, 444–452 (2024).
Abudayyeh, O. O. et al. A cytosine deaminase for programmable single-base RNA editing. Science 365, 382–386 (2019).
Rehmsmeier, M., Steffen, P., Hochsmann, M. & Giegerich, R. Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507–1517 (2004).
Wang, L. et al. Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Res. 27, 1289–1292 (2017).
Lei, L. et al. APOBEC3 induces mutations during repair of CRISPR–Cas9-generated DNA breaks. Nat. Struct. Mol. Biol. 25, 45–52 (2018).
Wang, X. et al. Efficient base editing in methylated regions with a human APOBEC3A–Cas9 fusion. Nat. Biotechnol. 36, 946–949 (2018).
Li, G. et al. Specific and efficient RNA A-to-I editing through cleavage of an ADAR inhibitor. https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1115824 (2025).
Li, G. et al. Specific and efficient RNA A-to-I editing through cleavage of an ADAR inhibitor. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267726 (2025).
Li, G. et al. Specific and efficient RNA A-to-I editing through cleavage of an ADAR inhibitor. https://ngdc.cncb.ac.cn/gsa-human/browse/HRA007429 (2025).
Li, G. et al. Specific and efficient RNA A-to-I editing through cleavage of an ADAR inhibitor. https://ngdc.cncb.ac.cn/gsa/browse/CRA016552 (2025).
Li, G. et al. Specific and efficient RNA A-to-I editing through cleavage of an ADAR inhibitor. GitHub https://github.com/YangLab/RtABE_computational_analysis (2025).
